Назва журналу :Annals of Oncology -2014р. т.25,N 8 Цікаві статті : Leighl N. B. Early-stage lung cancer-what do the experts recommend?/ N. B. Leighl, G. Curigliano (стр.1452-1453) Denkert C. The immunogenicity of breast cancer-molecular subtypes matter/ C. Denkert (стр.1453-1455) Curigliano G. Immunoscoring breast cancer: TILs remember what they target/ G. Curigliano, E. A. Perez (стр.1455-1456) Quinn D. I. Carboplatin's fourth decade: still searching for its sweet spot/ D. I. Quinn (стр.1457-1458) Casali P. G. Risks of the new EU Data protection regulation: an ESMO position paper endorsed by the European oncology community/ P. G. Casali (стр.1458-1460) 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up , J. Vansteenkiste, L. Crinò (стр.1462-1474) 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease , B. Besse, A. Adjei (стр.1475-1484) Quality assurance in the treatment of colorectal cancer: the EURECCA initiative , A. J. Breugom, P. G. Boelens (стр.1485-1492) Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force , M. Aapro, J. Arends (стр.1492-1499) ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas , M. Wilhelm, U. Dirksen (стр.1500-1505) Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research , P. K. Grover, A. G. Cummins (стр.1506-1516) Smoking and survival of colorectal cancer patients: systematic review and meta-analysis , V. Walter, L. Jansen (стр.1517-1525) Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies , F. Turati, C. Galeone (стр.1526-1535) Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients , H. R. Ali, E. Provenzano (стр.1536-1543) Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial , S. Loi, S. Michiels (стр.1544-1550) Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression , U. Nitz, O. Gluz (стр.1551-1557) Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO) , D. Zardavas, F. Ades (стр.1558-1561) Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial , A. Kramar, T. Bachelot (стр.1563-1570) Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact , J. M. Nabholtz, C. Abrial (стр.1571-1577) Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer , T. S. Mok, S. L. Geater (стр.1578-1584) SNPs in the transforming growth factor-β pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib , L. Zhang, Q. X. Li (стр.1584-1590) Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort , R. Cathomas, D. Klingbiel (стр.1591-1597) Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study , R. Buzzoni, S. Pusceddu (стр.1597-1603) A phase I study of cabozantinib (XL184) in patients with renal cell cancer , T. K. Choueiri, S. K. Pal (стр.1604-1608) Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) , M. Nitter, B. Norgård (стр.1609-1615) Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial , R. Glynne-Jones, L. Kadalayil (стр.1616-1622) ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial , N. Mounier, P. Brice (стр.1622-1628) Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor , Cecco L. De, P. Bossi (стр.1628-1635) Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA) , D. Blum, G. B. Stene (стр.1635-1642) Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors , D. Goldstein, M. L. Bell (стр.1643-1649) European cancer mortality predictions for the year 2014 , M. Malvezzi, P. Bertuccio (стр.1650-1656) Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors , J. Balmaña, N. M. Tung (стр.1656-1663) Malik L. The dilemmas of breast cancer treatment and increased fracture risk/ L. Malik (стр.1664) Bouvard B. The dilemmas of breast cancer treatment and increased fracture risk by Malik/ B. Bouvard, E. Legrand (стр.1664-1665) Laurent M. R. Fracture incidence after 3 years of aromatase inhibitor therapy/ M. R. Laurent, P. Neven, D. Vanderschueren (стр.1665-1666) Bouvard B. Reply to the letter to the editor ‘Fracture incidence after 3 years of aromatase inhibitor therapy’ by Laurent et al./ B. Bouvard, E. Legrand (стр.1666-1667) Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck , K. Misiukiewicz, M. Bonomi (стр.1667-1668) Pre-cachexia: a non-existing phenomenon in cancer? , S. Blauwhoff-Buskermolen, van der Schueren M. A. E. de (стр.1668-1669) Emile G. Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?/ G. Emile, E. Pujade-Lauraine, J. Alexandre (стр.1669-1670) RE: Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma , D. Diwakar, T. Choi (стр.1670-1671) Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer (стр.1672) Цікаві статті : Дод.точки доступу: Leighl, N. B.; Denkert, C.; Curigliano, G.; Quinn, D. I.; Casali, P. G.; Malik, L.; Bouvard, B.; Laurent, M. R.; Emile, G.; Perez, E. A.; Vansteenkiste, J.; Besse, B.; Breugom, A. J.; Aapro, M.; Wilhelm, M.; Grover, P. K.; Walter, V.; Turati, F.; Ali, H. R.; Loi, S.; Nitz, U.; Zardavas, D.; Kramar, A.; Nabholtz, J. M.; Mok, T. S.; Zhang, L.; Cathomas, R.; Buzzoni, R.; Choueiri, T. K.; Nitter, M.; Glynne-Jones, R.; Mounier, N.; De, Cecco L.; Blum, D.; Goldstein, D.; Malvezzi, M.; Balmaña, J.; Legrand, E.; Neven, P.; Misiukiewicz, K.; Blauwhoff-Buskermolen, S.; Pujade-Lauraine, E.; Diwakar, D.; Crinò, L.; Adjei, A.; Boelens, P. G.; Arends, J.; Dirksen, U.; Cummins, A. G.; Jansen, L.; Galeone, C.; Provenzano, E.; Michiels, S.; Gluz, O.; Ades, F.; Bachelot, T.; Abrial, C.; Geater, S. L.; Li, Q. X.; Klingbiel, D.; Pusceddu, S.; Pal, S. K.; Norgård, B.; Kadalayil, L.; Brice, P. ; Bossi, P.; Stene, G. B.; Bell, M. L.; Bertuccio, P.; Tung, N. M.; Vanderschueren, D.; Bonomi, M.; de, van der Schueren M. A. E.; Alexandre, J.; Choi, T.; Dooms, C.; Douillard, J. Y.; Faivre-Finn, C.; Lim, E.; Rocco, G.; Senan, S.; Van, Schil P.; Veronesi, G.; Stahel, R.; Peters, S.; Felip, E.; Baas, P.; Meldgaard, P.; Nicolson, M.; Paz-Ares, L.; Reck, M.; Smit, E. F.; Syrigos, K.; van, den Broek C. B. M.; Cervantes, A.; Van, Cutsem E.; Schmoll, H. J.; Valentini, V.; van, de Velde C. J. H.; Bozzetti, F.; Fearon, K.; Grunberg, S. M.; Herrstedt, J.; Hopkinson, J.; Jacquelin-Ravel, N.; Jatoi, A.; Kaasa, S.; Strasser, F.; Bielack, S. S.; Whelan, J. S.; Lewis, I. J.; Jürgens, H.; Ferrari, S.; Sundby, Hall K.; Cleton-Jansen, A. M.; Stark, D.; Price, T. J.; Roberts-Thomson, I. C.; Hardingham, J. E.; Hoffmeister, M.; Brenner, H.; Rota, M.; Pelucchi, C.; Negri, E.; Bagnardi, V.; Corrao, G.; Boffetta, P.; La, Vecchia C.; Dawson, S. -J.; Blows, F. M.; Liu, B.; Shah, M.; Earl, H. M.; Poole, C. J.; Hiller, L.; Dunn, J. A.; Bowden, S. J.; Twelves, C.; Bartlett, J. M. S.; Mahmoud, S. M. A.; Rakha, E.; Ellis, I. O.; Liu, S.; Gao, D.; Nielsen, T. O.; Pharoah, P. D. P.; Caldas, C.; Salgado, R.; Sirtaine, N.; Jose, V.; Fumagalli, D.; Kellokumpu-Lehtinen, P. -L.; Bono, P.; Kataja, V.; Desmedt, C.; Piccart, M. J.; Loibl, S.; Smyth, M. J.; Joensuu, H.; Sotiriou, C.; Huober, J.; Kreipe, H. H.; Kates, R. E.; Hartmann, A.; Erber, R.; Scholz, M.; Lisboa, B.; Mohrmann, S.; Möbus, V.; Augustin, D.; Hoffmann, G.; Weiss, E.; Böhmer, S.; Kreienberg, R.; Du, Bois A.; Sattler, D.; Thomssen, C.; Kiechle, M.; Jänicke, F.; Wallwiener, D.; Harbeck, N.; Kuhn, W.; Spasojevic, I. B.; Pugliano, L.; Capelan, M.; Paesmans, M.; de, Azambuja E.; Piccart, M.; Madrange, N.; Pierga, J. -Y.; Kerbrat, P.; Espié, M.; Fumoleau, P.; Pauporté, I.; Khayat, D.; Romieu, G.; Pivot, X.; Mouret-Reynier, M. A.; Dauplat, M. M.; Weber, B.; Gligorov, J.; Forest, A. M.; Tredan, O.; Vanlemmens, L.; Petit, T.; Guiu, S.; Van, Praagh I.; Jouannaud, C.; Dubray-Longeras, P.; Tubiana-Mathieu, N.; Benmammar, K. E.; Kullab, S.; Bahadoor, M. R. K.; Radosevic-Robin, N.; Kwiatkowski, F.; Desrichard, A.; Cayre, A.; Uhrhammer, N.; Chalabi, N.; Chollet, P.; Penault-Llorca, F.; Iannotti, N.; Thongprasert, S.; Spira, A.; Smith, D.; Lee, V.; Lim, W. T.; Reyderman, L.; Wang, B.; Gopalakrishna, P.; Garzon, F.; Xu, L.; Reynolds, C.; Wu, H. L.; Lu, X.; Yang, M.; Yu, S. Y.; Yuan, X. L.; Geldart, T. R.; Mead, G. M.; Ellis, S.; Wheater, M.; Simmonds, P.; Nagaraj, N.; von, R. Moos; Fehr, M.; Bajetta, E.; De, Braud F.; Platania, M.; Iannacone, C.; Cantore, M.; Mambrini, A.; Bertolini, A.; Alabiso, O.; Ciarlo, A.; Turco, C.; Mazzaferro, V.; McDermott, D. F.; Morrissey, S.; Ferguson, K. C.; Holland, J.; Kaelin, W. G.; Dutcher, J. P.; de, Vogel S.; Eussen, S. J. P. M.; Meyer, K.; Ulvik, A.; Ueland, P. M.; Nygård, O.; Vollset, S. E.; Bjørge, T.; Tjønneland, A.; Hansen, L.; Boutron-Ruault, M.; Racine, A.; Cottet, V.; Kaaks, R.; Kühn, T.; Trichopoulou, A.; Bamia, C.; Naska, A.; Grioni, S.; Palli, D.; Panico, S.; Tumino, R.; Vineis, P.; Bueno-de-Mesquita, H. B.; van, Kranen H.; Peeters, P. H.; Weiderpass, E.; Dorronsoro, M.; Jakszyn, P.; Sánchez, M.; Argüelles, M.; Huerta, J. M.; Barricarte, A.; Johansson, M.; Ljuslinder, I.; Khaw, K.; Wareham, N.; Freisling, H.; Duarte-Salles, T.; Stepien, M.; Gunter, M. J.; Riboli, E.; Meadows, H. M.; Cunningham, D.; Samuel, L.; Geh, J. I.; Lowdell, C.; James, R.; Beare, S.; Begum, R.; Ledermann, J. A.; Sebag-Montefiore, D.; Bologna, S.; Briere, J.; Gaillard, I.; M.; J.; Casasnovas, O.; Jaubert, J.; Colin, P.; Delmer, A.; Devidas, A.; Bachy, E.; Nicolas-Virelizier, E.; Aoudjhane, A.; Humbrecht, C.; Andre, M.; Carde, P.; Locati, L.; Canevari, S.; Licitra, L.; Solheim, T. S.; Fayers, P.; Hjermstad, M. J.; Baracos, V. E.; Kaasa S., S.,on behalf of Euro-Impact; Butow, P.; Sze, M.; Vaccaro, L.; Dong, S.; Liauw, W.; Hui, R.; Tattersall, M.; Ng, W.; Asghari, R.; Steer, C.; Vardy, J.; Parente, P.; Harris, M.; Karanth, N. V.; King, M.; Girgis, A.; Eisenbruch, M.; Jefford, M.; Levi, F.; Isakoff, S. J.; Graña, B.; Ryan, P. D.; Saura, C.; Lowe, E. S.; Frewer, P.; Winer, E.; Baselga, J.; Garber, J. E.; Demicco, E.; Posner, M.; Verheul, H. M. W.; Langius, J. A. E.; Tawbi, T. H.; Kirkwood, J. M.